EA
PRAH

Emerald Acquisition’s PRA Health Sciences, Inc. PRAH Stock Holding History

Emerald Acquisition’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$35.6M Buy
629,257
+72,340
+13% +$3.55M 0.07% 344
2016
Q2 		$23.3M Buy
+556,917
New +$25.7M 0.04% 525

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Emerald Acquisition's PRAH Position: Q3 2016 in Review

Emerald Acquisition increased its PRA Health Sciences, Inc. (PRAH) stake by 13% in Q3 2016, buying an estimated $3.55M and bringing the position to 629,257 shares worth $35.6M. The position accounts for 0.07% of the portfolio, ranked #344.

Emerald Acquisition first reported a position in PRAH in Q2 2016 and has held it in 2 quarters since. 172 funds tracked by Wall St. Rank hold PRAH as of Q3 2016.

  • Emerald Acquisition held 629,257 shares of PRA Health Sciences, Inc. worth $35.6M as of Q3 2016.
  • Emerald Acquisition bought 72,340 PRA Health Sciences, Inc. shares in Q3 2016, an estimated $3.55M.
  • PRA Health Sciences, Inc. made up 0.07% of Emerald Acquisition's portfolio in Q3 2016, its #344 holding.
  • Emerald Acquisition first reported a position in PRA Health Sciences, Inc. in Q2 2016 and has held it in 2 quarters since.
  • 172 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.